Abstract:In the author's institution, 2254 patients with hepatocellular carcinoma (HCC) have been treated during 1958-1994. The overall 5-year survival increased from 5.4% (1958-1970), to 11.9% (1971-1982), to 46.2% (1983-1984), which correlated well with the increasing proportion of small HCC in the series (2.6%, 12.1%, and 33.4%, respectively); with the increasing percentage of limited resection (3.1%, 32.2%, and 58.3%); with the increasing number of re-resections for recurrence (0, 27, and 114 patients); and with the increasing number of second stage resections (0, 5, and 67 patients). In our institution, surgical approaches that resulted in significantly prolonging survival included: small HCC resection, re-resection, and cytoreduction followed by sequential resection for initially unresectable HCC. Experience in these 3 aspects suggests: (a) Small HCCs are mainly found by screening using AFP and ultrasonography (US) in a high risk population, and limited resection is the best treatment in patients with compensated liver cirrhosis, the 5-year survival after resection being 62.9% (n = 549). (b) Postoperative monitoring using AFP/US every 2-3 months for 5-10 years after curative resection is needed to detect subclinical recurrence. Limited re-resection is indicated for liver recurrence less than 3 nodules, and lung lobectomy is of proven merit to prolong survival for solitary lung metastasis. Re-resection of subclinical recurrence has resulted in a 10-20% further increase in 5-year survival after curative resection. (c) Palliative surgery other than resection such as hepatic artery ligation (HAL) and cannulation with arterial infusion (HAI), cryosurgery, etc. are superior to palliative resection with residual cancer. (d) Cytoreduction and sequential resection have provided hope for localized unresectable HCC, particularly in the right cirrhotic liver. Multimodality combination treatments such as HAL+HAI+radioimmunotherapy/regional radiotherapy are acceptable cytoreductive therapies. Repeated transcatheter hepatic arterial chemoembolization (TACE) is an alternative nonsurgical approach. Sequential resection is important to eradicate residual cancer after cytoreduction. The 5-year survival of 72 patients with cytoreduction and sequential resection for initially unresectable HCC was 62.1% and resulted in improving 5-year survival in the entire series of unresectable HCC over the 3 periods from 0% to 7.4% to 25.7%, respectively. However, multicentric origin and tumor invasiveness are two major targets to be studied in the control of recurrence and metastasis.

Results of Liver Resection for Primary Liver Cancer

Retrospective Analysis on 682 Cases of Liver Cancer after Surgical Treatment

Long-term Survivors after Resection for Primary Liver Cancer. Clinical Analysis of 19 Patients Surviving More Than Ten Years

Results of Hepatectomy for Huge Primary Liver Cancer

Surgical Treatment of Primary Liver Cancer: Report of 5524 Patients

Hepatectomy for primary liver cancer in 1102 cases

Experiences in 467 Cases of Hepatic Resection

Long-term Results of Surgery for Small Primary Liver Cancer in 514 Adults

Hepatectomy Treating Primary Liver Cancer: 300 Cases Report

Surgery for Primary Liver Cancer: A Forty Years Survey

Results of Hepatectomy for 600 Cases with Primary Liver Cancer

Three Decades of Progress in Surgery for Primary Liver Cancer

Primary Tumor Resection for Rectal Cancer With Unresectable Liver Metastases: A Chance to Cut Is a Chance for Improved Survival

Surgical Treatment of Recurrent Hepatocellular Carcinoma.

[Surgery for Patients with Primary Liver Cancer: Report of 1,038 Patients].

Liver Resection for Noncolorectal Liver Metastases: an Analysis of 72 Patients

Surgical Resection Improves Long-Term Survival of Patients with Hepatocellular Carcinoma Across Different Barcelona Clinic Liver Cancer Stages.

Three Decades' Experience In Surgery Of Hepatocellular Carcinoma

Prognostic Factors Of Primary Liver-Cancer - Report Of 83 Patients Surviving 5 Years Or More Compared With 811 Patients Surviving Less Than 5 Years

A Surgery Oriented Serial Treatments of 191 Patients with Large Primary Liver Cancer

Surgical Treatment for Primary Liver Cancer